Discover 1,912 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,912
Active & Responsive
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
for
Gastric Adenocarcinoma,
Location: Dallas TX, Westwood KS, Chicago IL, Milwaukee WI,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT05365581
Phase1, Recruiting
Active & Responsive
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
for
Hereditary Hemorrhagic Telangiectasia,
Location: Dallas TX, St Louis MO, Birmingham AL, Aurora CO,
Sponsor: Cure HHT
Sex: All
Age: 0+
Code: NCT06259292
Recruiting
Active & Responsive
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
for
Mesial Temporal Lobe Epilepsy
Location: Dallas TX, Houston TX, Little Rock AR, New Orleans LA,
Sponsor: Neurona Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT05135091
Phase3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia
for
Non-Transfusion-dependent Alpha-Thalassemia,
Location: Dallas TX, Philadelphia PA, New York NY, Palo Alto CA
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07517133
Phase3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
for
Transfusion-dependent Alpha-Thalassemia,
Location: Dallas TX, Philadelphia PA, New York NY
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07506863
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
for
Cystic Fibrosis (CF), New Diagnostics
Location: Dallas TX, St Louis MO, Minneapolis MN, Milwaukee WI,
Sponsor: Chris Goss
Sex: All
Age: 16+
Code: NCT07312734
Recruiting
Active & Responsive
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
for
AML With Gene Mutations
Location: Dallas TX, Lawrence KS, Atlanta GA, Chicago IL,
Sponsor: Lomond Therapeutics Holdings, Inc.
Sex: All
Age: 18+
Code: NCT06366789
Phase1, Recruiting
Active & Responsive
A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.
for
Spasticity
Location: Dallas TX, Overland Park KS, Downey CA, Elkins Park PA
Sponsor: Ipsen
Sex: All
Age: 18 - 70
Code: NCT04752774
Phase1, Phase2, Recruiting
Active & Responsive
Efficacy and Safety of a Single Dose of LS301-IT for Fluorescence Intraoperative Molecular Imaging (IMI) for Patients Undergoing Lung Cancer Resection for Non Small Cell Lung Cancer
for
Non Small Cell Lung Cancer (NSCLC)
Location: Dallas TX, Philadelphia PA
Sponsor: Integro Theranostics
Sex: All
Age: 18+
Code: NCT07276789
Phase2, Recruiting
Active & Responsive
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
for
Phenylketonuria
Location: Dallas TX, Houston TX, Nashville TN, Chicago IL,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 18+
Code: NCT06971731
Phase3, Recruiting
Active & Responsive
A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Location: Dallas TX, Aurora CO, Atlanta GA, Minneapolis MN,
Sponsor: Spur Therapeutics
Sex: All
Age: 18+
Code: NCT07223944
Phase3, Recruiting
Active & Responsive
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Dallas TX, Jackson MS, Aurora CO, Nashville TN,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07100990
Phase3, Recruiting
Active & Responsive
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Dallas TX, San Antonio TX, Houston TX, Kansas City KS,
Sponsor: Nuvation Bio Inc.
Sex: All
Age: 18+
Code: NCT05303519
Phase3, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer